Can-Fite BioPharma Ltd. (CANF)
3.08
+0.05
(+1.65%)
USD |
NYAM |
Apr 08, 16:00
3.04
-0.04
(-1.30%)
After-Hours: 06:17
Can-Fite BioPharma Enterprise Value : -4.850M for April 8, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Compugen Ltd. | 73.85M |
| Pluri, Inc. | 61.10M |
| BioLineRx Ltd. | 4.431M |
| XTL Biopharmaceuticals Ltd. | -- |
| Evogene Ltd. | 9.214M |
Enterprise Value Related Metrics
| Earnings Yield | -400.3% |
| Normalized Earnings Yield | -400.04 |